Archives

by in
Entry Author Date Location
With FDA Nod, T2 Bio’s Sepsis Test Heads to Commercial Proving Ground 09/23/14 Boston
East Coast Biotech Roundup: Amicus, Accelerator, Seventh Sense, & More 08/15/14 Boston
Novartis Helps Pour $16M Into Seventh Sense for Pain-Free Blood Tests 08/13/14 Boston
T2 Biosystems Sputters Through IPO Queue, Raises $57M 08/07/14 Boston
Langer, Led Zeppelin, and Hookups: Three Days Behind the BIO Scenes 06/27/14 San Diego
East Coast Biotech Roundup: Bluebird, Moderna, Navitor, & More 06/20/14 Boston
Kala Pharma Grabs $22.5M More For Eye Drugs 04/23/14 Boston
Former MIT President Charles Vest Dead of Cancer at 72 12/13/13 Boston
East Coast Life Sciences Roundup: ASCO, Follica, Aveo, & More 06/07/13 Boston
Bind Therapeutics, AstraZeneca Collaborate on Cancer Drug 04/22/13 Boston
Boston Biotech Seizes the Momentum: Last Chance for Early Bird Tix 03/07/13 Boston
Kala Pharma, From MIT & Johns Hopkins, Grabs $11.5M for Eye Drugs 02/28/13 Boston
Join Us for ‘Boston Biotech Seizes the Momentum’ on April 4 02/07/13 Boston
Lee Hood, Bob Langer Win National Medals 12/21/12 Seattle
Moderna, $40M in Tow, Hopes to Reinvent Biotech with “Make Your Own Drug” 12/06/12 Boston
Semprus, Nara, UberSense, & More Names from the Boston Deal Roundup 06/27/12 Boston
The Convergence of Biology, Medicine, and Engineering 01/18/12 Boston
The Boston Life Sciences Newsmakers: Civitas, Blend, Forma, & More 01/13/12 Boston
LogMeIn, Safari, Forma, And More Behind the Boston-Area Deals News 01/11/12 Boston
Langer, Farokhzad Start New Combo Drug Company, Blend Therapeutics 01/06/12 Boston
Editor’s Picks: Xconomy Boston’s Top 20ish Stories of 2011 12/28/11 Boston
Best Buy Picks Up MindShift, Termeer Funds NanoString, Basho Adds $5M More, & More Boston-Area Deals News 11/09/11 Boston
Langer Nabs Cash From Rock Stars, Verastem Seeks $50M IPO, Alnylam Snags RNAi Collab, & More Boston-Area Life Sciences News 11/04/11 Boston
Bob Langer’s Latest Project: Fix Damaged Vocal Cords for Rock Stars, Cancer Patients 11/02/11 Boston
Editor’s Picks: Xconomy Boston’s Top 20 Stories of the Third Quarter 10/28/11 Boston
BIND and Selecta Pull in $50M from Russian Fund Seeking to Advance Nano-Drugs 10/27/11 Boston
Xconomist of the Week: Bob Langer’s Advice for Turning Foundation and Government Money into Startup Success 09/01/11 Boston
T2 Biosystems Closes $23M More for Fast, Cheap Diagnostic Tools 08/10/11 Boston
Biogen Eyes Cambridge Move, Vertex Licenses Alios Drugs, Concert Nabs GSK Payment, & More Boston-Area Life Sciences News 06/24/11 Boston
MIT’s Bob Langer Strikes Again, Wins Priestley Medal 06/13/11 Boston
Page 1 of 4 next page »